AzTrials
AzTrials

SARS-CoV-2 InfectionNCT05713305

Effect of an Online Self-help Psychological Intervention on Non-ICU Specialty Care During the COVID-19 Outbreak

A study testing Online-based self-help psychological intervention and Provide online mental health knowledge in people with SARS-CoV-2 Infection and Staff Attitude, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Timely interventions may reduce the occurrence of post-traumatic stress disorder (PTSD) in ICU medical staff. Existing research suggests that either self-learning psychological relief methods or seeking online counseling or therapy from professional psychotherapists during the SARS-CoV-2 Omicron outbreak has the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
SARS-CoV-2 Infection, Staff Attitude, Anxiety
What is being tested?
Online-based self-help psychological intervention and Provide online mental health knowledge
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
110 participants
Where
1 siteChina
Study dates
18 Jan 2023to 20 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Non-ICU professional staff providing direct health care services to critically ill SARS-CoV-2 Omicron patients in the ICU
  • Signing the informed consent form

Who cannot join

  • No reported acute suicidal tendencies
  • No history of psychotic or dissociative symptoms
  • Pregnancy or lactation
  • Major family changes within the last 12 weeks( For e.g. death of immediate family member)
  • Participated in other clinical trials

Trial locations and contacts

1 site in 1 country.

China1 site
  • The Second Affiliated Hospital of Zhejiang University anesthesiology department

    Hangzhou, Zhejiang, 310000

Other trials in China

About this study

Official title: Effect of an Online Self-help Psychological Intervention on the Physical and Mental Health of Non-professional Staff Who Supported the ICU During the Omicron Outbreak: a Randomized Controlled Trial

Timely interventions may reduce the occurrence of post-traumatic stress disorder (PTSD) in ICU medical staff. Existing research suggests that either self-learning psychological relief methods or seeking online counseling or therapy from professional psychotherapists during the SARS-CoV-2 Omicron outbreak has the potential to alleviate the emotional distress and promote the physical and mental health of health care workers. Web-based online mental health interventions complemented by joint effective mental health advice can further reduce harmful negative effects.

Being tested
Online-based self-help psychological intervention, Provide online mental health knowledge
Medical subject headings
COVID-19, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online-based self-help psychological interventionProcedure or surgery

    Daily members of the intervention group were thought to provide three different forms of daily sessions each day, averaging 10-20 minutes. These sessions included psycho-educational and cognitive-behavioral exercises, music therapy, sleep hygiene, stress relief methods. Weekly online lecture sessions presented by professional mental health therapists

  • Provide online mental health knowledgeProcedure or surgery

    They will receive official mental health recommendations on how to cope mentally with the pandemic. These recommendations inform about the importance of a daily structure, social contact, acceptance of negative emotions and strengthening of positive emotions, and stimulus control to assimilate SARS-CoV-2 Omicron-related news

Study groups in NCT05713305
Study groupRoleWhat they receive
Intervention groupExperimentalDaily members of the intervention group were thought to provide three different forms of daily sessions each day, averaging 10-20 minutes. These sessions included psycho-educational and cognitive-behavioral exercises, music therapy, sleep hygiene, stress relief methods. Weekly online lecture sessions presented by professional mental health therapists. In-depth interviews are conducted both before and after the experiment to explore the feasibility of the intervention
Receives: Procedure: Online-based self-help psychological intervention
Control groupPlacebo comparatorThey will receive official mental health recommendations on how to cope mentally with the pandemic. These recommendations inform about the importance of a daily structure, social contact, acceptance of negative emotions and strengthening of positive emotions, and stimulus control to assimilate SARS-CoV-2 Omicron-related news. In-depth interviews are conducted both before and after the experiment to explore the feasibility of the intervention
Receives: Procedure: Provide online mental health knowledge

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in medical staff DASS-21( Depression Anxiety Stress Scale 21) after 28 days of intervention

    DASS-21 changes( 0-63), The larger the score, the worse the result

    Measured: 28 days after intervention

Secondary outcomes (7)
  1. Proportion of depression and anxiety problems among different types of staff

    Proportion of depression and anxiety

    Measured: 28 days after intervention

  2. The degrees to which depression and anxiety problems occur in different types of staff

    The degrees to which depression and anxiety problems

    Measured: 28 days after intervention

  3. Incidence of posttraumatic stress disorder

    Incidence of posttraumatic stress disorder

    Measured: 28 days after intervention

  4. Well-being was measured with the WHO-5 well-being index

    Well-being was measured with the WHO-5 well-being index ( 0-25), The higher the score, the higher the happiness index

    Measured: 28 days after intervention

  5. Improvement in sleep quality

    Improvement in sleep quality( ISI), insomnia severity index ( 0-28) , The larger the score, the worse the result

    Measured: 28 days after intervention

  6. Results of the Depression Anxiety Stress Scale 21 scale after 3 months of intervention

    DASS-21 changes( 0-63), The larger the score, the worse the result ,after three months of intervention

    Measured: Three months after intervention

  7. Results of the Depression Anxiety Stress Scale 21 scale after 6 months of intervention

    DASS-21 changes( 0-63), The larger the score, the worse the result, after 6 months of intervention

    Measured: 6 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2023
  2. Study start18 Jan 2023
  3. Primary completion20 Jun 2023
  4. Study completion20 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05713305
Sponsor's protocol ID
2023-0023
Status last verified
Jan 2023
First submitted
18 Jan 2023
Last updated
5 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Online-based self-help psychological intervention and Provide online mental health knowledge in people with SARS-CoV-2 Infection and Staff Attitude, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in medical staff DASS-21( Depression Anxiety Stress Scale 21) after 28 days of intervention (time frame: 28 days after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in